MiR-125a-3p and MiR-320b Differentially Expressed in Patients with Chronic Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Imatinib Mesylate

MiR-125a-3p and MiR-320b Differentially Expressed in Patients with Chronic Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Imatinib Mesylate

Chronic myeloid leukemia (CML), a hematopoietic neoplasm arising from the fusion of BCR (breakpoint cluster region) gene on chromosome 22 to the ABL (Abelson leukemia virus) gene on chromosome 9 (BCR-ABL1 oncogene), originates from a small population of leukemic stem cells with extensive capacity fo...

Full description

Bibliographic Details
Main Authors: Juliana R. B. Martins, Leonardo N. Moraes, Sarah S. Cury, Juliana Capannacci, Robson Francisco Carvalho, Célia Regina Nogueira, Newton Key Hokama, Paula O. M. Hokama
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
chronic myeloid leukemia
allogeneic hematopoietic stem cell transplantation
imatinib mesylate
miRNAs
miR-125a-3p
miR-320b
Online Access:https://www.mdpi.com/1422-0067/22/19/10216

Internet

https://www.mdpi.com/1422-0067/22/19/10216

Similar Items